|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/63 | |
| C12N 15/113 | |||
| C07H 19/00 | |||
| A61K 31/712 | |||
| C12Q 1/68 | |||
| A61P 9/00 |
| (11) | Number of the document | 2370581 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09831074.1 |
| Date of filing the European patent application | 2009-12-02 | |
| (97) | Date of publication of the European application | 2011-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/066455 |
| Date | 2009-12-02 |
| (87) | Number | WO 2010/065671 |
| Date | 2010-06-10 |
| (30) | Number | Date | Country code |
| 119957 P | 2008-12-04 | US |
| (72) |
COLLARD, Joseph, US
KHORKOVA SHERMAN, Olga, US
|
| (73) |
CuRNA, Inc.,
4400 Biscayne Boulevard, Miami, FL 33137,
US
|
| (54) | TREATMENT OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO VEGF |
| TREATMENT OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO VEGF |